Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Tay

Showing results (41-50 of 82) with videos related to

Pageof 9
Sort By:
Current Oncology (Toronto, Ont.)|September 27, 2024
Doxycycline Plus Bortezomib-Containing Regimens for the Treatment of Light-Chain Amyloidosis in the Frontline Setting: Experience from the Amyloidosis Program of CalgaryEllen Lewis, Nowell Fine, Sylvia McCulloch, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|May 14, 2014
Noninfectious pulmonary complications after hematopoietic stem cell transplantation: practical approach to imaging diagnosisElena Peña, Carolina A Souza, Dante L Escuissato, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 17, 2022
Real-world Outcomes With Cumulative Bortezomib Dose and Efficacy in the Treatment of Transplant-ineligible Multiple Myeloma With Cyclophosphamide, Bortezomib, and DexamethasoneChunpeng Nie, Holly Lee, Jason Tay, et al.
Transfusion|July 29, 2016
Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trialsGrace Christou, Ahbinav Iyengar, Risa Shorr, et al.
Clinical Transplantation|April 3, 2019
Clinical outcomes of polyvalent immunoglobulin use in solid organ transplant recipients: A systematic review and meta-analysisSamuel Bourassa-Blanchette, Greg A Knoll, Brian Hutton, et al.
Leukemia & Lymphoma|June 14, 2019
Slow lenalidomide desensitization protocol for patients with multiple myeloma: case series from a single centerPatrick Yau, Victor H Jimenez-Zepeda, Kyla Bailey, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2023
Monoclonal Gammopathy of Undetermined Significance in Patients With Transthyretin Amyloidosis (ATTR): Analysis Using the iStopMM CriteriaEllen Lewis, Holly Lee, Nowell Fine, et al.
BMC Palliative Care|July 1, 2021
Perceptions of healthcare professionals towards palliative care in internal medicine wards: a cross-sectional surveyJason Tay, Scott Compton, Gillian Phua, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 22, 2017
Early Relapse for Multiple Myeloma Patients Undergoing Single Autologous Stem Cell Therapy: A Single-center ExperienceHolly Lee, Peter Duggan, Ahsan Chaudhry, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 9, 2013
Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?Natasha Kekre, Melanie Tokessy, Ranjeeta Mallick, et al.
Pageof 9

Showing results (41-50 of 82) with videos related to

Sort By:
Pageof 9
Current Oncology (Toronto, Ont.)|September 27, 2024
Doxycycline Plus Bortezomib-Containing Regimens for the Treatment of Light-Chain Amyloidosis in the Frontline Setting: Experience from the Amyloidosis Program of CalgaryEllen Lewis, Nowell Fine, Sylvia McCulloch, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc|May 14, 2014
Noninfectious pulmonary complications after hematopoietic stem cell transplantation: practical approach to imaging diagnosisElena Peña, Carolina A Souza, Dante L Escuissato, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 17, 2022
Real-world Outcomes With Cumulative Bortezomib Dose and Efficacy in the Treatment of Transplant-ineligible Multiple Myeloma With Cyclophosphamide, Bortezomib, and DexamethasoneChunpeng Nie, Holly Lee, Jason Tay, et al.
Transfusion|July 29, 2016
Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trialsGrace Christou, Ahbinav Iyengar, Risa Shorr, et al.
Clinical Transplantation|April 3, 2019
Clinical outcomes of polyvalent immunoglobulin use in solid organ transplant recipients: A systematic review and meta-analysisSamuel Bourassa-Blanchette, Greg A Knoll, Brian Hutton, et al.
Leukemia & Lymphoma|June 14, 2019
Slow lenalidomide desensitization protocol for patients with multiple myeloma: case series from a single centerPatrick Yau, Victor H Jimenez-Zepeda, Kyla Bailey, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 9, 2023
Monoclonal Gammopathy of Undetermined Significance in Patients With Transthyretin Amyloidosis (ATTR): Analysis Using the iStopMM CriteriaEllen Lewis, Holly Lee, Nowell Fine, et al.
BMC Palliative Care|July 1, 2021
Perceptions of healthcare professionals towards palliative care in internal medicine wards: a cross-sectional surveyJason Tay, Scott Compton, Gillian Phua, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 22, 2017
Early Relapse for Multiple Myeloma Patients Undergoing Single Autologous Stem Cell Therapy: A Single-center ExperienceHolly Lee, Peter Duggan, Ahsan Chaudhry, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 9, 2013
Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?Natasha Kekre, Melanie Tokessy, Ranjeeta Mallick, et al.
Pageof 9